Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (251-260 of 325) with videos related to

Pageof 33
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'IvoireEric N Ouattara, Eric L Ross, Yazdan Yazdanpanah, et al.
AIDS (London, England)|February 8, 2024
Age-associated dementia among older people aging with HIV in the United States: a modeling studyEmily P Hyle, Nattanicha Wattananimitgul, Shibani S Mukerji, et al.
JAMA Network Open|February 2, 2019
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United StatesQiushi Chen, Marc R Larochelle, Davis T Weaver, et al.
BMC Infectious Diseases|August 27, 2013
A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trialIngrid V Bassett, Janet Giddy, Christine E Chaisson, et al.
Open Forum Infectious Diseases|May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
Plos One|November 15, 2014
HIV cure strategies: how good must they be to improve on current antiretroviral therapy?Paul E Sax, Alexis Sypek, Bethany K Berkowitz, et al.
Antiviral Therapy|January 30, 2003
Lifetime cost of HIV care in France during the era of highly active antiretroviral therapyYazdan Yazdanpanah, Sue J Goldie, Elena Losina, et al.
Plos One|January 28, 2014
Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectivenessIngrid V Bassett, Darshini Govindasamy, Alison S Erlwanger, et al.
JAMA Network Open|November 28, 2023
Projected Life Expectancy Gains From Improvements in HIV Care in Black and White Men Who Have Sex With MenKatherine M Rich, Ankur Pandya, John J Chiosi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 22, 2014
Cost-effectiveness of genotype testing for primary resistance in BrazilPaula M Luz, Bethany L Morris, Beatriz Grinsztejn, et al.
Pageof 33

Showing results (251-260 of 325) with videos related to

Sort By:
Pageof 33
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'IvoireEric N Ouattara, Eric L Ross, Yazdan Yazdanpanah, et al.
AIDS (London, England)|February 8, 2024
Age-associated dementia among older people aging with HIV in the United States: a modeling studyEmily P Hyle, Nattanicha Wattananimitgul, Shibani S Mukerji, et al.
JAMA Network Open|February 2, 2019
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United StatesQiushi Chen, Marc R Larochelle, Davis T Weaver, et al.
BMC Infectious Diseases|August 27, 2013
A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trialIngrid V Bassett, Janet Giddy, Christine E Chaisson, et al.
Open Forum Infectious Diseases|May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
Plos One|November 15, 2014
HIV cure strategies: how good must they be to improve on current antiretroviral therapy?Paul E Sax, Alexis Sypek, Bethany K Berkowitz, et al.
Antiviral Therapy|January 30, 2003
Lifetime cost of HIV care in France during the era of highly active antiretroviral therapyYazdan Yazdanpanah, Sue J Goldie, Elena Losina, et al.
Plos One|January 28, 2014
Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectivenessIngrid V Bassett, Darshini Govindasamy, Alison S Erlwanger, et al.
JAMA Network Open|November 28, 2023
Projected Life Expectancy Gains From Improvements in HIV Care in Black and White Men Who Have Sex With MenKatherine M Rich, Ankur Pandya, John J Chiosi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 22, 2014
Cost-effectiveness of genotype testing for primary resistance in BrazilPaula M Luz, Bethany L Morris, Beatriz Grinsztejn, et al.
Pageof 33